About the Research

The Research Team

Led from inside the population it serves

Dr. Chris Slininger
Principal Investigator

This work is led by someone who understands the population it serves from the inside. Dr. Chris Slininger served in the United States Army from 2004 to 2013, including service overseas during Operation Iraqi Freedom. Between athletics and military service he sustained roughly ten mild traumatic brain injuries, and by the time he left service he was living with significant cognitive decline.

Through the same kind of care this study investigates, he experienced a recovery that did not simply return his brain to its pre-service baseline but carried his cognitive function beyond anything he had known before. It is precisely because he knows how persuasive a personal story can be that he insists this study not rest on one — a single recovery is an anecdote, and anecdotes do not change national policy. The study is designed to let the science lead and the evidence shape the conclusion, whatever it turns out to be.

Investigators

Billiris
Co-Investigator

Co-investigator on the clinical protocol, contributing craniocervical expertise across the pilot and the full randomized trial.

Kalambaheti
Co-Investigator

Co-investigator supporting protocol delivery and participant care across the study’s treatment lanes.

Cabrera
Research Director

Directs research operations — coordinating data systems, imaging pipeline, and two-site execution across every phase.

The Scientific Coalition

Institutional Partners

Advanced Orthogonal Institute (dba Craniocervical Institute)

Principal Research Sponsor · 501(c)(3)

A Florida 501(c)(3) nonprofit and the clinical and scientific home of the study, coordinating protocol design, craniocervical care, and the imaging program across all four phases.

Cerebral Chiropractic Center of Tampa Bay

Clinical Partner

A treating clinical site contributing craniocervical expertise and participant care within the study protocol.

Genesis Brain Institute

Research Partner

Contributing neurological research capacity and analytic support toward the trial’s outcome measures and publication.

Last updated August 15, 2026